Sign up to save your podcasts
Or
Share The Evolving Relationship Between Real World Data and Clinical Trials with Nancy Dreyer and C.K. Wang
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
The Evolving Relationship Between Real World Data and Clinical Trials with Nancy Dreyer and C.K. Wang
n this episode of Real World Talk, host Zoe Li talks to Nancy Dreyer, Chief Scientific Officer of IQVIA, and COTA’s own Chief Medical Officer, Dr. C.K. Wang.
They discuss the interactions between real world data and clinical trials, and how the two approaches can complement each other. They also look at why the Lancet retracted a large study into the use of hydroxychloroquine to treat COVID-19 in June, after questions were raised about its curation and application of real world data.
View all episodes
By COTA
5
11 ratings
n this episode of Real World Talk, host Zoe Li talks to Nancy Dreyer, Chief Scientific Officer of IQVIA, and COTA’s own Chief Medical Officer, Dr. C.K. Wang.
They discuss the interactions between real world data and clinical trials, and how the two approaches can complement each other. They also look at why the Lancet retracted a large study into the use of hydroxychloroquine to treat COVID-19 in June, after questions were raised about its curation and application of real world data.